Pentosan Polysulfate Treatment of Mucopolysaccharidosis Type IIIA Mice.

No abstract is available for this paper.

• Publication year

  2019

• Venue

  JIMD Reports

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/8904_2018_96PMID 29654542PMCID PMC6323024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety Study of Sodium Pentosan Polysulfate for Adult Patients with Mucopolysaccharidosis Type II

  2019cited by this paper
• Enzyme replacement therapy.

  2019cited by this paper
• Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA

  2017cited by this paper
• Age, sex, and gonadal hormones differently influence anxiety- and depression-related behavior during puberty in mice.

  2017cited by this paper
• Axonal dystrophy in the brain of mice with Sanfilippo syndrome

  2017cited by this paper
• How close are we to therapies for Sanfilippo disease?

  2017cited by this paper
• Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice

  2017cited by this paper
• Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial.

  2017cited by this paper
• Broad Th2 neutralization and anti‐inflammatory action of pentosan polysulfate sodium in experimental allergic rhinitis

  2017cited by this paper
• Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study

  2016cited by this paper
• Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs

  2016cited by this paper
• A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA.

  2016cited by this paper
• Sodium Pentosan Polysulfate Reduced Renal Ischemia-Reperfusion-Induced Oxidative Stress and Inflammatory Responses in an Experimental Animal Model

  2016cited by this paper
• Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease

  2015cited by this paper
• Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.

  2015cited by this paper
• Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain

  2015cited by this paper
• Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment

  2014cited by this paper
• Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity

  2014cited by this paper
• Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses

  2013cited by this paper
• Therapies for human prion diseases.

  2013cited by this paper
• Blood-brain barrier impairment in MPS III patients

  2013influential reference
• Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB

  2012cited by this paper
• Abnormal Gangliosides are Localized in Lipid Rafts in Sanfilippo (MPS3a) Mouse Brain

  2012cited by this paper
• Protease‐resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion

  2012cited by this paper
• Pentosan Polysulfate

  2012influential reference
• Blood-Brain Barrier Impairment in an Animal Model of MPS III B

  2011cited by this paper
• Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice

  2011cited by this paper
• A rotarod test for evaluation of motor skill learning.

  2010cited by this paper
• Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.

  2010cited by this paper
• Less protease‐resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate

  2010cited by this paper
• Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy

  2009influential reference
• Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

  2009cited by this paper
• Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK

  2008cited by this paper
• LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.

  2007cited by this paper
• Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B.

  2007cited by this paper
• Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases.

  2007cited by this paper
• Neuroprotective effect of pentosan polysulphate on ischemia-related neuronal death of the hippocampus.

  2006cited by this paper
• Neurofibrillary tangles in Niemann-Pick disease type C

  2004cited by this paper
• Enzyme-Replacement Therapy from Birth Delays the Development of Behavior and Learning Problems in Mucopolysaccharidosis Type IIIA Mice

  2004cited by this paper
• A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).

  1999cited by this paper
• Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies.

  1999cited by this paper
• 尿路結石発症におけるクエン酸およびsodium pentosan polysulfateの抑制効果

  1996cited by this paper
• Neurofibrillary tangles in Niemann-Pick disease type C.

  1995cited by this paper
• Sanfilippo syndrome type D.

  1987influential reference
• Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.

  1980influential reference
• Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.

  1978influential reference
• Human alpha-n-acetylglucosaminidase. 2. Activity towards natural substrates and multiple recognition forms.

  1977cited by this paper
• Human alpha-n-acetylglucosaminidase. 2. Activity towards natural substrates and multiple recognition forms.

  1977influential reference
• Mucopolysaccharidosis III A (Sanfilippo A disease): Deficiency of a heparin sulfamidase in skin fibroblasts and leucocytes

  1973influential reference

• Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders

  2024cites this paper
• Open‐label, single‐center, clinical study evaluating the safety, tolerability and clinical effects of pentosan polysulfate sodium in subjects with mucopolysaccharidosis I

  2024cites this paper
• Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy

  2024cites this paper
• The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis

  2023cites this paper
• Glycosaminoglycan-induced proinflammatory cytokine levels as disease marker in mucopolysaccharidosis.

  2023cites this paper
• Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?

  2023cites this paper
• The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy

  2022cites this paper
• Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets

  2022cites this paper
• Hip pathologies in mucopolysaccharidosis type III

  2021cites this paper
• Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome).

  2020cites this paper
• Novel therapies for mucopolysaccharidosis type III

  2020cites this paper
• Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments

  2019cites this paper
• Safety Study of Sodium Pentosan Polysulfate for Adult Patients with Mucopolysaccharidosis Type II

  2019cites this paper
• Recent trends in mucopolysaccharidosis research

  2018cites this paper
• The role of innate immunity in mucopolysaccharide diseases

  2018cites this paper